Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04305158 · ClinicalTrials.gov registry record · Early Phase 1
Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA
A Early Phase 1 study of Nitrous Oxide, sponsored by University of Arkansas.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04305158 is a Early Phase 1 study of Nitrous Oxide that has completed, run by University of Arkansas. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04305158, a Early Phase 1 study of Nitrous Oxide, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Colon cancer is the second most common cancer in men and the third most common cancer in women worldwide. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of N2O could potentially provide an alternate safe and cheap option for patients who do not prefer IV sedation for colonoscopy
Conditions Studied
Interventions
- DRUG Nitrous Oxide
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2023-08-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04305158
The ClinicalTrials.gov registry entry for NCT04305158 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nitrous Oxide appearing as the primary indexed condition, and to 1 intervention - of which Nitrous Oxide is the first listed.
NCT04305158 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT04305158 about?
NCT04305158 is a clinical study titled "Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA". Colon cancer is the second most common cancer in men and the third most common cancer in women worldwide. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of N2O could potentially provi...
What is the current status of trial NCT04305158?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 200 participants. The study started on 2022-03-28. Estimated completion is 2023-08-10.
What conditions does trial NCT04305158 study?
This clinical trial studies the following conditions: Nitrous Oxide.
What interventions are being tested in trial NCT04305158?
The interventions under investigation include: Nitrous Oxide (DRUG).
Who is sponsoring clinical trial NCT04305158?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04305158 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.